Jeff Knight

Jeff Knight

Geschäftsführer bei CRINETICS PHARMACEUTICALS, INC.

Vermögen: 2 Mio $ am 30.04.2024

52 Jahre
Health Technology
Consumer Services

Ursprung des Netzwerks ersten Grades von Jeff Knight

EinheitArt der EinheitIndustrie
46
Subsidiary Pharmaceuticals: Major 46
Public Company Pharmaceuticals: Major 40
Public Company Pharmaceuticals: Major 21
Public Company Biotechnology 15
Public Company Biotechnology 8

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Jeff Knight

UnternehmenSektorVerknüpfte PersonenHauptposition
BRISTOL-MYERS SQUIBB COMPANY Pharmaceuticals: Major

Helen Torley

Stuart Tross

Vance D. Coffman

N. Coles

Bernadette Connaughton

Michael Castagna

John Tsai

Loren Wagner

Corporate Officer/Principal

Human Resources Officer

Director/Board Member

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Private Equity Investor

Corporate Officer/Principal

ELI LILLY AND COMPANY Pharmaceuticals: Major

William Ringo

Thomas Wiggans

Rolf K. Hoffmann

Diana McKenzie

Steve Knowles

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

College/University

N. Coles

Camille Bedrosian

James Ferguson

Jacqueline Pomfret Kirby

Paul Kassner

Graduate Degree

Undergraduate Degree

Undergraduate Degree

Graduate Degree

Doctorate Degree

University of Michigan College/University

Antonio J. Grillo-López

John E. Osborn

Rekha Hemrajani

Caryn McDowell

Daniel Mikol

Corporate Officer/Principal

Corporate Officer/Principal

Undergraduate Degree

Undergraduate Degree

Corporate Officer/Principal

The Johns Hopkins University College/University

John E. Osborn

N. Coles

Bernadette Connaughton

Wen Chen Yeh

Graduate Degree

Director/Board Member

Undergraduate Degree

Doctorate Degree

Stanford University College/University

Julianna R. Wood

Vance D. Coffman

Wendell Wierenga

Corinne Nevinny

Undergraduate Degree

Doctorate Degree

Doctorate Degree

Undergraduate Degree

The Royal College of Physicians College/University

Helen Torley

Richard Bryce

Steve Knowles

Rosh Dias

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Miscellaneous Commercial Services

Pablo Cagnoni

Helen Torley

Thomas Wiggans

N. Coles

Director/Board Member

Director/Board Member

Director/Board Member

Director/Board Member

PFIZER, INC. Pharmaceuticals: Major

Robert Scott

Wendell Wierenga

William Ringo

Catherine Mackey

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

NEUROCRINE BIOSCIENCES, INC. Pharmaceuticals: Major

Wendell Wierenga

Corinne Nevinny

Scott Struthers

Stephen Betz

Chief Tech/Sci/R&D Officer

Director/Board Member

Director/Board Member

Corporate Officer/Principal

The Wharton School of the University of Pennsylvania College/University

Yujiro Hata

Bernadette Connaughton

Michael Castagna

Masters Business Admin

Masters Business Admin

Masters Business Admin

VERTEX PHARMACEUTICALS INCORPORATED Pharmaceuticals: Major

N. Coles

Diana McKenzie

Reshma Kewalramani

Corporate Officer/Principal

Director/Board Member

Chief Executive Officer

Harvard Business School College/University

Fred Hassan

Corinne Nevinny

Robert Azelby

Masters Business Admin

Masters Business Admin

Masters Business Admin

NOVARTIS AG Pharmaceuticals: Major

Pablo Cagnoni

Michael Castagna

John Tsai

Corporate Officer/Principal

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

RAPT THERAPEUTICS, INC. Pharmaceuticals: Major

Yujiro Hata

Rekha Hemrajani

Paul Kassner

Chief Operating Officer

Chief Operating Officer

Corporate Officer/Principal

DERMIRA, INC. Pharmaceuticals: Major

William Ringo

Thomas Wiggans

Matthew Fust

Director/Board Member

Chief Executive Officer

Director/Board Member

University of California San Diego College/University

Antonio J. Grillo-López

Yujiro Hata

Scott Struthers

Director/Board Member

Corporate Officer/Principal

Doctorate Degree

Investment Trusts/Mutual Funds

Pablo Cagnoni

John E. Osborn

N. Coles

Corporate Officer/Principal

Corporate Officer/Principal

Director/Board Member

College/University

Harry Leonhardt

Masaru Matsuda

Loren Wagner

Graduate Degree

Undergraduate Degree

Graduate Degree

Medical Specialties

Corinne Nevinny

Rogério Vivaldi Coelho

Stephanie Okey

Director/Board Member

Corporate Officer/Principal

Corporate Officer/Principal

SANGAMO THERAPEUTICS, INC. Biotechnology

Julianna R. Wood

William Ringo

Thomas Wiggans

Public Communications Contact

Chairman

Director/Board Member

Medical Specialties

David J. Scott

Marcea Lloyd

Mark Gergen

General Counsel

Corporate Officer/Principal

Corporate Officer/Principal

Pharmaceuticals: Major

Ellen Kullman

Antonio J. Grillo-López

John E. Osborn

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

The University of North Carolina at Chapel Hill College/University

Rolf K. Hoffmann

Stephen Betz

Feng Ye

Masters Business Admin

Doctorate Degree

Doctorate Degree

College/University

Ellen Kullman

Marcea Lloyd

Alan Krasner

Director/Board Member

Graduate Degree

Undergraduate Degree

UNITY BIOTECHNOLOGY, INC. Biotechnology

Susan R. Lundeen-Smuck

Robert Goeltz

Michael Samar

Human Resources Officer

Director of Finance/CFO

Director/Board Member

College/University

Stuart Tross

Catherine Mackey

Weston Nichols

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

EDITAS MEDICINE, INC. Biotechnology

Cynthia Collins

Caren Deardorf

Bernadette Connaughton

Chief Executive Officer

Corporate Officer/Principal

Director/Board Member

Harvard Medical School College/University

N. Coles

Camille Bedrosian

Corporate Officer/Principal

Doctorate Degree

ARCUS BIOSCIENCES, INC. Biotechnology

Rekha Hemrajani

Robert Goeltz

Director of Finance/CFO

Director of Finance/CFO

Pharmaceuticals: Major

Marion McCourt

Jane Chung

Chief Executive Officer

President

DERMTECH, INC. Medical Specialties

Cynthia Collins

Patrick Johnson

Director/Board Member

Chief Tech/Sci/R&D Officer

REGENERON PHARMACEUTICALS, INC. Pharmaceuticals: Major

N. Coles

Marion McCourt

Director/Board Member

Corporate Officer/Principal

ATYR PHARMA, INC. Pharmaceuticals: Major

Svetlana Lucas

Danielle Campbell

Director/Board Member

Human Resources Officer

AVANIR PHARMACEUTICALS INC Pharmaceuticals: Major

Corinne Nevinny

Garlan Adams

Director/Board Member

Comptroller/Controller/Auditor

FIVE PRIME THERAPEUTICS, INC. Biotechnology

Jonathan Graham

William Ringo

General Counsel

Chief Executive Officer

ASSEMBLY BIOSCIENCES, INC. Pharmaceuticals: Major

William Ringo

Michael Samar

Chairman

Director of Finance/CFO

Pharmaceuticals: Major

Fred Hassan

Diana McKenzie

Chairman

Corporate Officer/Principal

Miscellaneous Commercial Services

Ellen Kullman

Vance D. Coffman

Corporate Officer/Principal

Corporate Officer/Principal

Kellogg School of Management College/University

Ellen Kullman

Rekha Hemrajani

Graduate Degree

Masters Business Admin

Tufts University College/University

Ellen Kullman

Caren Deardorf

Corporate Officer/Principal

Undergraduate Degree

PORTOLA PHARMACEUTICALS, INC. Pharmaceuticals: Major

William Ringo

Mike Ouimette

Director/Board Member

Corporate Officer/Principal

College/University

Weston Nichols

Svetlana Lucas

Doctorate Degree

Doctorate Degree

University of Toronto College/University

Wen Chen Yeh

James Hassard

Corporate Officer/Principal

Undergraduate Degree

INTERMUNE INC Biotechnology

William Ringo

Caryn McDowell

Chief Executive Officer

Corporate Officer/Principal

Statistik

International

Vereinigte Staaten 47
Kanada 3
Vereinigtes Königreich 2
Schweiz 2

Sektoral

Health Technology 30
Consumer Services 18
Commercial Services 4
Miscellaneous 2

Operativ

Director/Board Member 359
Corporate Officer/Principal 257
Independent Dir/Board Member 131
Chief Tech/Sci/R&D Officer 89
Undergraduate Degree 87
  1. Börse
  2. Insiders
  3. Jeff Knight
  4. Unternehmensverbindungen
-40 % Zeitlich begrenztes Angebot: Unsere Abonnements führen Sie zu den besten Investitionen von morgen.
PROFITIEREN SIE JETZT